<h1>Legal risks for fertility clinic's phygital platform: advertising claims, informed consent, privacy, device approvals, screening transparency</h1> A national fertility clinic chain announces a new digital 'phygital' platform offering free online wellness sessions, expert webinars, and selective in-person embryology lab tours, alongside low-cost screening packages and published success-rate claims. Legal considerations include advertising and consumer protection scrutiny of success-rate and efficacy claims, compliance with medical and assisted-reproductive regulations for lab access and embryo handling, informed-consent and privacy protections for visitors and online participants, liability for alleged misinformation or clinical outcomes, and transparency in pricing and promotional terms. Regulatory approvals for medical devices and secure handling/identification systems should be documented and disclosed.